Hepion Pharmaceuticals files Form 3 showing KI Holdings as 10% owner - HEPA News | RalliesHepion Pharmaceuticals files Form 3 showing KI Holdings as 10% owner
H
HEPA• KI Holdings reports 10% ownership in Hepion Pharmaceuticals
- KI Holdings filed a Form 3 for Hepion Pharmaceuticals, reporting 10 million shares of common stock held indirectly.
- The filing also lists 10 million warrants exercisable at $0.06, expiring Aug. 3, 2031.
- KI Holdings reported 10% owner status, with the event date listed as Aug. 3, 2026.
•
